REQUEST A DEMO
Total
USD $0.00
Search more companies

Surien Pharmaceuticals Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Surien Pharmaceuticals Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Surien Pharmaceuticals Private Limited is an unlisted company, incorporated on 19/04/2004. It has its registered office in the State of Tamil Nadu, India. Company's corporate identification number (CIN) is U24232TN2004PTC053031 and registration number is 053031. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
108, Chekkadi Street, Kovur
Chennai; Tamil Nadu; Postal Code: 602101

Contact Details: Purchase the Surien Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Surien Pharmaceuticals Private Limited report to view the information.
Outstanding Shares:
Purchase the Surien Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Surien Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Surien Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
April 19, 2004
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
60%
Purchase this report to view the information.
40%
Company Performance
Financial values in the chart are available after Surien Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-22.72%
Total operating revenue
-22.71%
Operating profit (EBIT)
-8.38%
EBITDA
-2.83%
Net Profit (Loss) for the Period
18.6%
Total assets
-21.41%
Total equity
1.23%
Operating Profit Margin (ROS)
0.05%
Net Profit Margin
0.05%
Return on Equity (ROE)
0.18%
Debt to Equity Ratio
0.61%
Quick Ratio
0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?